Arkolith/Insider Trading/LGND/Form 4

Aryeh Jason

DirectorLIGAND PHARMACEUTICALS INC (LGND) · full profile →Form 4 · filed Jun 12, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.3M
Net Open-Market Flow
-$1.3M
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 11, 2026Sell(S)5K$250.00$1.1M103K
Jun 10, 2026Sell(S)500$250.00$125K107K
Jun 5, 2026Grant(A)836—$0108K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 5, 2026Grant(A)3K—$03K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002001011-26-000103) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML